| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer
1 company
Burkly Linda is an EVP, Chief Scientific Officer at EDIT. Recent filings cover 0 purchases and 10 sales. Those positions are worth an estimated $187K at current prices.
Our model assigns Burkly Linda a below-average insider score of 48/100, based on 6 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -9.3%.
Burkly Linda's largest disclosed position is in EDIT as EVP, Chief Scientific Officer, worth about $187K. The recent filings there lean toward selling, a net 29,164 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 709 | $3.04 | $2,153.37 | -1.1% | - | - | |
| Jul 28, 2026 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 4,928 | $2.67 | $13,157.76 | -7.3% | -8.4% | - | |
| Jun 3, 2026 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 731 | $2.70 | $1,974.50 | -1.1% | +10.4% | - | |
| Mar 3, 2026 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 749 | $2.02 | $1,512.68 | -1.1% | +63.7% | - | |
| Dec 3, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 713 | $2.15 | $1,535.16 | -1.0% | -13.7% | - | |
| Sep 3, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 710 | $2.60 | $1,843.23 | -1.0% | -15.6% | +23.2% | |
| Jul 31, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 5,121 | $2.49 | $12,756.92 | -7.4% | +21.1% | +2.8% | |
| Jun 3, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 726 | $1.72 | $1,251.84 | -1.0% | +35.7% | +52.7% | |
| Mar 4, 2025 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 2,891 | $1.71 | $4,945.63 | -4.0% | +0.6% | +25.0% | |
| Jul 25, 2024 | EDIT Editas Medicine, Inc. | EVP, Chief Scientific Officer | Sell | 11,886 | $5.42 | $64,369.82 | -14.0% | -42.4% | -43.4% |